<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Adaptable Segmentation Pipeline for Diverse Brain Tumors with Radiomic-guided Subtyping and Lesion-Wise Model Ensemble - Health AI Hub</title>
    <meta name="description" content="This paper introduces a flexible, modular, and adaptable pipeline for robust segmentation of diverse brain tumors on multi-parametric MRI, addressing challenges">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Adaptable Segmentation Pipeline for Diverse Brain Tumors with Radiomic-guided Subtyping and Lesion-Wise Model Ensemble</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.14648v1" target="_blank">2512.14648v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-16
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Daniel Capell√°n-Mart√≠n, Abhijeet Parida, Zhifan Jiang, Nishad Kulkarni, Krithika Iyer, Austin Tapp, Syed Muhammad Anwar, Mar√≠a J. Ledesma-Carbayo, Marius George Linguraru
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, eess.IV
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.14648v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.14648v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a flexible, modular, and adaptable pipeline for robust segmentation of diverse brain tumors on multi-parametric MRI, addressing challenges posed by varying tumor types. It improves performance by integrating state-of-the-art models, applying radiomic-guided subtyping for balanced training, and utilizing custom lesion-wise processing steps. The pipeline achieved competitive results on various BraTS challenge datasets, demonstrating the efficacy of lesion-aware processing and model selection for generalizable segmentation.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research significantly enhances the accuracy and adaptability of brain tumor segmentation, a foundational step for quantitative tumor measurement. Such improvements are crucial for precise diagnosis, reliable prognosis assessment, and effective treatment planning in neuro-oncology.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application is an adaptable segmentation pipeline for automated and robust identification and measurement of diverse brain tumors (including adult, pediatric, meningioma, and metastases) from multi-parametric MRI scans. This AI-powered system provides quantitative tumor measurements, which are intended to support clinical diagnosis and prognosis for individual patients.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical challenge of robust and generalizable brain tumor segmentation due to wide variations in tumor types (e.g., adult, pediatric, meningioma, metastases).</li>
                    
                    <li>Proposes a flexible and modular pipeline that selects and combines state-of-the-art segmentation models rather than relying on a single network architecture.</li>
                    
                    <li>Incorporates tumor- and lesion-specific pre- and post-processing steps, tailoring the workflow to individual cases for refined predictions.</li>
                    
                    <li>Leverages radiomic features extracted from MRI to detect tumor subtypes, which helps ensure a more balanced and effective training process across diverse tumor pathologies.</li>
                    
                    <li>Utilizes custom lesion-level performance metrics to optimally determine the influence of each model within the ensemble and refine post-processing steps.</li>
                    
                    <li>Achieved performance comparable to top-ranked algorithms across multiple BraTS 2025 Lighthouse Challenge datasets, including PED, MEN, MEN-RT, and MET challenges.</li>
                    
                    <li>Key finding emphasizes that custom lesion-aware processing and intelligent model selection are paramount for robust segmentation, independent of locking the method to a specific network architecture.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The methodology involves a flexible, modular segmentation pipeline designed to select and combine state-of-the-art deep learning models. It applies tumor- and lesion-specific processing both before and after model training. Radiomic features extracted from MRI are used for tumor subtype detection to enable balanced training across diverse tumor types. Custom lesion-level performance metrics are employed to optimize the contribution of each model in the ensemble and to refine post-processing steps. The pipeline was rigorously evaluated on high-quality, diverse datasets from the BraTS 2025 Lighthouse Challenge, encompassing pediatric brain tumors, meningiomas (preoperative and radiotherapy), and brain metastases.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The pipeline demonstrated performance comparable to leading algorithms across various challenging BraTS 2025 testing sets, including those for pediatric brain tumors, meningiomas, and brain metastases. The study confirmed that custom lesion-aware processing and strategic model selection are crucial for achieving robust and generalizable segmentations, highlighting that superior performance is not solely dependent on a specific network architecture.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This adaptable segmentation method holds significant potential for clinical integration, enabling more accurate and reliable quantitative tumor measurement in routine practice. It can directly support improved diagnosis, more precise prognosis prediction, and better-informed treatment planning and monitoring for patients with a wide array of brain tumors.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not explicitly mentioned in the abstract.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly outlining future research directions, the abstract highlights the method's potential for direct application in clinical practice for quantitative tumor measurement, supporting diagnosis and prognosis, implying future work would focus on clinical validation and integration.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neuro-oncology</span>
                    
                    <span class="tag">Radiology</span>
                    
                    <span class="tag">Medical Imaging</span>
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Pediatric Oncology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Brain Tumors</span>
                    
                    <span class="tag tag-keyword">MRI Segmentation</span>
                    
                    <span class="tag tag-keyword">Radiomics</span>
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                    <span class="tag tag-keyword">Model Ensemble</span>
                    
                    <span class="tag tag-keyword">Neuro-oncology</span>
                    
                    <span class="tag tag-keyword">BraTS Challenge</span>
                    
                    <span class="tag tag-keyword">Medical Imaging</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Robust and generalizable segmentation of brain tumors on multi-parametric magnetic resonance imaging (MRI) remains difficult because tumor types differ widely. The BraTS 2025 Lighthouse Challenge benchmarks segmentation methods on diverse high-quality datasets of adult and pediatric tumors: multi-consortium international pediatric brain tumor segmentation (PED), preoperative meningioma tumor segmentation (MEN), meningioma radiotherapy segmentation (MEN-RT), and segmentation of pre- and post-treatment brain metastases (MET). We present a flexible, modular, and adaptable pipeline that improves segmentation performance by selecting and combining state-of-the-art models and applying tumor- and lesion-specific processing before and after training. Radiomic features extracted from MRI help detect tumor subtype, ensuring a more balanced training. Custom lesion-level performance metrics determine the influence of each model in the ensemble and optimize post-processing that further refines the predictions, enabling the workflow to tailor every step to each case. On the BraTS testing sets, our pipeline achieved performance comparable to top-ranked algorithms across multiple challenges. These findings confirm that custom lesion-aware processing and model selection yield robust segmentations yet without locking the method to a specific network architecture. Our method has the potential for quantitative tumor measurement in clinical practice, supporting diagnosis and prognosis.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>12 pages, 5 figures, 3 tables. Algorithm presented at MICCAI BraTS 2025</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>